Lemaitre Vascular (LMAT) Tops Q1 EPS by 3c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/1/2026
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil jumps 2%, settles at 6-month highs on fears of escalation in Iran
- Qualcomm shares fall on Intel warning and legal concerns
- Marvell Technology shares drop on Lumentum deal concerns
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Oracle shares drop on AI spending concerns and Microsoft criticism
- SpaceX stock drops on launch setback and sector selloff
- After-Hours Movers: AMZN, TWLO, INTC, SNDK, RDDT, RBLX, PINS, RIVN, SBUX, ILMN
- After-Hours Movers: GOOGL, MSFT, NOW, KLAC. CMG, CVNA, TDOC
- After-Hours Movers: STX, ENPH, HOOD, V, CSGP, BOOM, CAKE, PPG, OI, TER
- After-Hours Movers: CLS, AVGO, CDNS, AMKR, WHR
- After-Hours Movers: WDC, BE, DECK, FIX, RNG
LeMaitre Q1 2015 Record Sales $18.9mm (+13%), Op. Inc. $2.3mm
April 28, 2015 4:06 PM EDTBURLINGTON, Mass., April 28, 2015 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq: LMAT), a provider of vascular devices, today reported Q1 2015 results, announced a $0.04/share dividend and provided guidance.
Q1 2015 results included:
Record sales of $18.9mm, +13% vs. Q1 2014 Operating income of $2.3mm vs. an operating loss of $0.2mm Operating margin of 12% Net income of $1.4mm vs. a net loss of $0.2mm Earnings of $0.08 per diluted share vs. ($0.01) EBITDA of $3.2mm vs. $0.6mmQ1 2015 sales of $18.9mm increased 13% (+14% organic) vs. Q1 2014. International sales increased 15%, while The Americas... More
LeMaitre Q1 2015 Record Sales $18.9mm (+13%), Op. Inc. $2.3mm
April 28, 2015 4:05 PM EDTBURLINGTON, Mass., April 28, 2015 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq: LMAT), a provider of vascular devices, today reported Q1 2015 results, announced a $0.04/share dividend and provided guidance.
Q1 2015 results included:
Record sales of $18.9mm, +13% vs. Q1 2014 Operating income of $2.3mm vs. an operating loss of $0.2mm Operating margin of 12% Net income of $1.4mm vs. a net loss of $0.2mm Earnings of $0.08 per diluted share vs. ($0.01) EBITDA of $3.2mm vs. $0.6mmQ1 2015 sales of $18.9mm increased 13% (+14% organic) vs. Q1 2014. International sales increased 15%, while The Americas... More



